QQQ   355.29 (+0.61%)
AAPL   181.68 (+0.61%)
MSFT   327.94 (+0.82%)
META   265.65 (+0.40%)
GOOGL   122.93 (+0.65%)
AMZN   124.01 (-0.19%)
TSLA   245.91 (+4.70%)
NVDA   391.05 (+1.55%)
NIO   7.93 (+1.80%)
BABA   86.19 (+0.06%)
AMD   124.88 (+3.16%)
T   16.00 (-0.44%)
F   13.81 (+1.69%)
MU   65.44 (+0.18%)
CGC   0.67 (-3.39%)
GE   106.05 (-0.02%)
DIS   91.97 (-0.61%)
AMC   4.74 (+1.28%)
PFE   38.92 (-0.43%)
PYPL   63.86 (-0.59%)
NFLX   425.30 (+3.89%)
QQQ   355.29 (+0.61%)
AAPL   181.68 (+0.61%)
MSFT   327.94 (+0.82%)
META   265.65 (+0.40%)
GOOGL   122.93 (+0.65%)
AMZN   124.01 (-0.19%)
TSLA   245.91 (+4.70%)
NVDA   391.05 (+1.55%)
NIO   7.93 (+1.80%)
BABA   86.19 (+0.06%)
AMD   124.88 (+3.16%)
T   16.00 (-0.44%)
F   13.81 (+1.69%)
MU   65.44 (+0.18%)
CGC   0.67 (-3.39%)
GE   106.05 (-0.02%)
DIS   91.97 (-0.61%)
AMC   4.74 (+1.28%)
PFE   38.92 (-0.43%)
PYPL   63.86 (-0.59%)
NFLX   425.30 (+3.89%)
QQQ   355.29 (+0.61%)
AAPL   181.68 (+0.61%)
MSFT   327.94 (+0.82%)
META   265.65 (+0.40%)
GOOGL   122.93 (+0.65%)
AMZN   124.01 (-0.19%)
TSLA   245.91 (+4.70%)
NVDA   391.05 (+1.55%)
NIO   7.93 (+1.80%)
BABA   86.19 (+0.06%)
AMD   124.88 (+3.16%)
T   16.00 (-0.44%)
F   13.81 (+1.69%)
MU   65.44 (+0.18%)
CGC   0.67 (-3.39%)
GE   106.05 (-0.02%)
DIS   91.97 (-0.61%)
AMC   4.74 (+1.28%)
PFE   38.92 (-0.43%)
PYPL   63.86 (-0.59%)
NFLX   425.30 (+3.89%)
QQQ   355.29 (+0.61%)
AAPL   181.68 (+0.61%)
MSFT   327.94 (+0.82%)
META   265.65 (+0.40%)
GOOGL   122.93 (+0.65%)
AMZN   124.01 (-0.19%)
TSLA   245.91 (+4.70%)
NVDA   391.05 (+1.55%)
NIO   7.93 (+1.80%)
BABA   86.19 (+0.06%)
AMD   124.88 (+3.16%)
T   16.00 (-0.44%)
F   13.81 (+1.69%)
MU   65.44 (+0.18%)
CGC   0.67 (-3.39%)
GE   106.05 (-0.02%)
DIS   91.97 (-0.61%)
AMC   4.74 (+1.28%)
PFE   38.92 (-0.43%)
PYPL   63.86 (-0.59%)
NFLX   425.30 (+3.89%)
OTCMKTS:PRVCF

PreveCeutical Medical (PRVCF) Stock Forecast, Price & News

$0.02
0.00 (0.00%)
(As of 06/8/2023 ET)
Compare
Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.02
52-Week Range
$0.01
$0.03
Volume
47 shs
Average Volume
34,693 shs
Market Capitalization
$11.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PRVCF stock logo

About PreveCeutical Medical (OTCMKTS:PRVCF) Stock

PreveCeutical Medical, Inc. engages in licensing, branding, and marketing of nutraceutical and wellness products. The company was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman, and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.

Receive PRVCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter.

PRVCF Stock News Headlines

All Electric Commitment From GM, Volkswagen, Could Put Lithium Sector In A Supercycle
More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...
PRVCF PreveCeutical Medical Inc.
All Electric Commitment From GM, Volkswagen, Could Put Lithium Sector In A Supercycle
More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...
PreveCeutical Files Application for D-amino Acid Peptides
PreveCeutical Announces Conversion of Debt
PREVECEUTICAL MED. (18H.BE)
See More Headlines

PRVCF Price History

PRVCF Company Calendar

Today
6/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PRVCF
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.01) per share

Miscellaneous

Free Float
N/A
Market Cap
$11.67 million
Optionable
Not Optionable
Beta
0.87

Key Executives

  • Stephen van Deventer
    Chairman, Chief Executive & Financial Officer
  • Makarand Jawadekar
    President, Director & Chief Science Officer
  • Harry Parekh
    Chief Research Officer
  • Alicia Rebman
    Marketing Director













PRVCF Stock - Frequently Asked Questions

How have PRVCF shares performed in 2023?

PreveCeutical Medical's stock was trading at $0.0179 on January 1st, 2023. Since then, PRVCF shares have increased by 21.8% and is now trading at $0.0218.
View the best growth stocks for 2023 here
.

What is PreveCeutical Medical's stock symbol?

PreveCeutical Medical trades on the OTCMKTS under the ticker symbol "PRVCF."

How do I buy shares of PreveCeutical Medical?

Shares of PRVCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PreveCeutical Medical's stock price today?

One share of PRVCF stock can currently be purchased for approximately $0.02.

How much money does PreveCeutical Medical make?

PreveCeutical Medical (OTCMKTS:PRVCF) has a market capitalization of $11.67 million.

How can I contact PreveCeutical Medical?

PreveCeutical Medical's mailing address is 1177 West Hastings Street Suite 2200, Vancouver A1, V6E2K3. The official website for the company is www.preveceutical.com. The company can be reached via phone at (604) 416-7777, via email at ir@preveceutical.com, or via fax at 778-945-6290.

This page (OTCMKTS:PRVCF) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -